Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Laser versus electrohydraulic treatment for hard-to-remove common bile duct stones

Official title: Efficacy and Safety of Laser Versus Electrohydraulic Lithotripsy for Difficult Biliary Stones: A Randomized Controlled Trial

Run by Mahidol University · NCT07030829 · Data updated 2026-11-12

This trial tests whether laser or electrohydraulic lithotripsy is better at breaking up difficult common bile duct stones in adults who could not have their stones removed with standard ERCP techniques.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorMahidol University
Academic / other
Locations2 sites (Bangkok, Bangkok and 1 other locations)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJune 22, 2025
Trial IDNCT07030829 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with difficult common bile duct stones (for example stones >1.5 cm, impacted stones, multiple stones, or stones not cleared by conventional ERCP) are ideal candidates.

Probably not a fit

Patients with surgically altered anatomy, uncorrected bleeding disorders, unstable vital signs, or who are pregnant are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with difficult common bile duct stones undergo single-operator cholangioscopy (SpyGlass) and lithotripsy to fragment stones that could not be removed by conventional ERCP methods. One group receives laser lithotripsy and the other receives electrohydraulic lithotripsy, with fragments removed by standard ERCP retrieval techniques. The trial compares rates of complete stone clearance, number of procedures required, and complication rates between the two approaches. Adults with large, impacted, multiple, or hard-to-reach stones are included while those with unstable vitals, uncorrected coagulopathy, or surgically altered anatomy are excluded.

Why it matters

Potential benefit: If successful, the preferred method could increase first-line clearance of difficult stones, reduce repeat procedures, and lower complication rates.

How similar studies have gone: Previous case series and comparative reports using SpyGlass-directed EHL or laser lithotripsy have demonstrated successful stone fragmentation, but head-to-head randomized data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged \>18 years
* Difficult CBD stone
* Large CBD stone (stone \> 1.5 cm) or Stone impaction or CBD stones that were not completely removed using conventional techniques.

Exclusion Criteria:

* Pregnancy
* Unstable vital signs
* Severe comorbidities
* Uncorrected coagulopathy
* Surgically altered anatomy
* Unable to complete informed consent

Where it's running

  • Faculty of Medicine Siriraj Hospital, Mahidol University
    Bangkok, Bangkok, Thailand
    Recruiting
  • Faculty of Medicine Siriraj Hospital, Mahidol University
    Bangkok, Bangkok, Thailand
    Recruiting

Study contacts

  • Principal investigator: Varayu Prachayakul, MD — Mahidol University
  • Study coordinator: Ronnakorn Kongsakon, MD
  • Email: ronnagorn@gmail.com
  • Phone: +66655979522

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.